![]() Paresthesia was noted in 46.2% of PTS individuals and a sensory loss was reported in 34.6% of patients. Among them, 93.8% of patients had severe pain, 80.8% were reported to present a motor deficit, and 53.8% of patients presented muscle wasting. The clinical and paraclinical spectrum was heterogeneous, ranging from classical PTS to pure sensory neuropathy, extended neuropathy, spinal accessory nerve involvement, and diaphragmatic palsy. ![]() We found 26 cases of PTS in patients with previous SARS-CoV-2 infection. We systematically reviewed two databases (LitCOVID and the World Health Organization database on COVID-19) to January 2023. In addition, we aimed to highlight research gaps requiring further attention. We aimed to investigate data on PTS triggered by SARS-CoV-2 infection to provide an extensive perspective on this pathology and to reveal what other, more specific, research questions can be further addressed. Recently, PTS was reported following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ![]() Hypothesized underlying causes focus on immune-mediated processes, as more than half of patients present some antecedent event or possible predisposing condition, such as infection, vaccination, exercise, or surgery. Parsonage-Turner syndrome (PTS) is an inflammatory disorder of the brachial plexus.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |